3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Dermatologic
1
Classical hematology
1
Conditions
Febrile Neutropenia
2
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Lymphoma
1
Leukemia
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Interventions
Vancomycin
2
Meropenem
2
Ceftazidime
2
pegfilgrastim
1
ofatumumab
1
Teicoplanin
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Piperacillin, Tazobactam Drug Combination
1
Metformin
1
Lenalidomide
1
Cloxacillin
1
Cilastatin, Imipenem Drug Combination
1
Cefepime
1
Bevacizumab
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fever
×
Piperacillin, Tazobactam Drug Combination
×
Classical hematology
×
Clear all
NCT02463747
2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4
Unknown
110 enrolled